Rejection in the setting of combined Heart and Liver Transplantation by Shuktika Nandkeolyar, Tripti Gupta, D. Marshall Brinkley, Sophoclis Alexopoulos, Emily Firsich, Sally Anne Fossey, Rachel Fowler, Benjamin Frischhertz, Kimberly Harrison, JoAnn Lindenfeld, Martin Montenovo, Dawn Pedrotty, Lynn Punnoose, Aniket Rali, Alexandra Shingina, Kelly Schlendorf, Hasan Siddiqi, Ashish Shah, Sandip Zalawadiya, Mark Wigger, Jonathan N. Menachem

Get full text

Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study by Andreas Krisl, Susanne Stampf, Dimitri Hauri, Isabelle Binet, Thomas Mueller, Daniel Sidler, Karine Hadaya, Déla Golshayan, Manuel Pascual, Michael Koller, Michael Dickenmann, the Swiss Transplant Cohort Study (STCS)

“…The incidence of graft loss was significantly higher in patients with ciclosporin-based than with tacrolimus-based immunosuppression (adjusted hazard ratio [HR] 1.66, 95% confidence interval [CI] 1.29–2.14; p <0.01), but the occurrence of acute transplant rejections did not differ significantly (adjusted HR 1.48, 95% CI 0.82–2.65; p = 0.19). …”
Get full text